Purdue, other drugmakers race to launch tamper-resistant drugs

04/28/2008 | Bloomberg11

Purdue Pharma LP next week will present a new formulation of its painkiller OxyContin to a panel of outside advisers to the FDA, as it competes with other companies to introduce tamper-resistant drugs that addicts cannot abuse. Alpharma, Pain Therapeutics and Elite Pharmaceuticals are working on alternative treatments to capture a share of a market that could be worth $1 billion.

View Full Article in:

Bloomberg11

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX